Home > Boards > US Listed > Biotechs > Halozyme Therapeutics (HALO)

I wish you were right about the billion

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
maumar Member Profile
Member Level 
Followed By 4
Posts 352
Boards Moderated 0
Alias Born 09/28/12
160x600 placeholder
Halozyme Announces CRADA With National Institute of Allergy and Infectious Diseases For Use Of ENHANZE® Drug Delivery Techno... PR Newswire (US) - 6/25/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2019 8:20:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2019 1:41:16 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/7/2019 5:11:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 4:45:58 PM
Halozyme To Participate In Upcoming Investor Conferences PR Newswire (US) - 6/4/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 5:24:28 PM
Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement PR Newswire (US) - 5/22/2019 1:05:00 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 5/14/2019 5:11:52 PM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 5/14/2019 5:08:35 PM
Halozyme To Participate In Bank of America Merrill Lynch Health Care Conference 2019 PR Newswire (US) - 5/13/2019 8:01:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 4:14:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 4:07:11 PM
Halozyme Reports First Quarter 2019 Results PR Newswire (US) - 5/7/2019 4:01:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/6/2019 4:02:13 PM
Halozyme Names Dr. Alison A. Armour As Senior Vice President Of Research And Development PR Newswire (US) - 5/6/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/3/2019 5:08:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:30:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:26:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:23:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:21:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:18:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:14:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:11:43 PM
Halozyme To Host First Quarter 2019 Financial Results Webcast And Conference Call PR Newswire (US) - 4/23/2019 4:01:00 PM
maumar Member Level  Friday, 02/22/19 01:33:38 PM
Re: Fred Kadiddlehopper post# 5599
Post # of 5632 
I wish you were right about the billion dollars in milestone payments in the next two or three years but Laurie Stelzer said $225/$230M, which is still significant, and one billion over the lifetime of all the products that are in the clinic.

Laurie Stelzer

Hi there. So as far as milestones that would be associated in that same timeframe, I can point it to two things. The first, we have given some projection to the milestones that we would achieve between 2019 and '21 of about $225 million to $230 million. We've also said that over the life of the products that are in the clinic, we would expect to see about $1 billion and that would be in total lifetime milestones assuming achievement of all events as our partners progress their programs to the clinic. So hopefully that helps frame that kind of the size and shape of the milestones expectation.

https://seekingalpha.com/article/4243162-halozyme-therapeutics-inc-halo-ceo-dr-helen-torley-q4-2018-results-earnings-call-transcript?part=single

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist